Prestige Consumer Healthcare In - stock earnings
PBH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 53.0 million USD | 282.7 million USD |
| 2023Q3 | 53.6 million USD | 286.3 million USD |
| 2023Q2 | 53.3 million USD | 279.3 million USD |
| 2023Q1 | -240.6 million USD | 285.9 million USD |
| 2022Q4 | 52.0 million USD | 275.5 million USD |
| 2022Q3 | 51.0 million USD | 289.3 million USD |
| 2022Q2 | 55.3 million USD | 277.1 million USD |
| 2022Q1 | 52.1 million USD | 266.9 million USD |
| 2021Q4 | 50.2 million USD | 274.5 million USD |
| 2021Q3 | 45.3 million USD | 276.2 million USD |
| 2021Q2 | 57.8 million USD | 269.2 million USD |
| 2021Q1 | 35.5 million USD | 237.8 million USD |
| 2020Q4 | 40.9 million USD | 238.8 million USD |
| 2020Q3 | 44.6 million USD | 237.4 million USD |
| 2020Q2 | 43.7 million USD | 229.4 million USD |
| 2020Q1 | 37.0 million USD | 251.2 million USD |
| 2019Q4 | 38.1 million USD | 241.6 million USD |
| 2019Q3 | 33.3 million USD | 238.1 million USD |
| 2019Q2 | 33.9 million USD | 232.2 million USD |
| 2019Q1 | -139.3 million USD | 241.0 million USD |
| 2018Q4 | 38.2 million USD | 241.4 million USD |
| 2018Q3 | 30.8 million USD | 239.4 million USD |
| 2018Q2 | 34.5 million USD | 254.0 million USD |
| 2018Q1 | -39.7 million USD | 256.0 million USD |
| 2017Q4 | 314.8 million USD | 270.6 million USD |
| 2017Q3 | 30.7 million USD | 258.0 million USD |
| 2017Q2 | 33.8 million USD | 256.6 million USD |
| 2017Q1 | 11.1 million USD | 240.7 million USD |
| 2016Q4 | 31.6 million USD | 216.8 million USD |
| 2016Q3 | 32.2 million USD | 215.1 million USD |
| 2016Q2 | -5.5 million USD | 209.6 million USD |
| 2016Q1 | 13.9 million USD | 207.9 million USD |
| 2015Q4 | 28.0 million USD | 200.2 million USD |
| 2015Q3 | 31.8 million USD | 206.1 million USD |
| 2015Q2 | 26.2 million USD | 192.1 million USD |
| 2015Q1 | 23.8 million USD | 190.0 million USD |
| 2014Q4 | 21.3 million USD | 197.6 million USD |
| 2014Q3 | 16.5 million USD | 181.3 million USD |
| 2014Q2 | 16.7 million USD | 145.7 million USD |
| 2014Q1 | 16.0 million USD | 144.3 million USD |
| 2013Q4 | 3.1 million USD | 146.2 million USD |
| 2013Q3 | 32.8 million USD | 168.4 million USD |
| 2013Q2 | 20.7 million USD | 143.0 million USD |
| 2013Q1 | 19.3 million USD | 154.5 million USD |
| 2012Q4 | 12.3 million USD | 160.2 million USD |
| 2012Q3 | 19.2 million USD | 161.9 million USD |
| 2012Q2 | 14.7 million USD | 147.0 million USD |
| 2012Q1 | -15000 USD | 134.0 million USD |
| 2011Q4 | 9.5 million USD | 106.3 million USD |
| 2011Q3 | 12.9 million USD | 105.5 million USD |
| 2011Q2 | 14.8 million USD | 95.3 million USD |
| 2011Q1 | 6.4 million USD | 96.4 million USD |
| 2010Q4 | 2.2 million USD | 90.6 million USD |
| 2010Q3 | 11.0 million USD | 78.3 million USD |
| 2010Q2 | 9.6 million USD | 73.4 million USD |
| 2010Q1 | 3.3 million USD | 71.4 million USD |
| 2009Q4 | 10.6 million USD | 75.4 million USD |
| 2009Q3 | 9.9 million USD | 84.2 million USD |
| 2009Q2 | 8.3 million USD | 73.2 million USD |
| 2009Q1 | -211.1 million USD | 70.9 million USD |
| 2008Q4 | 8.0 million USD | 80.3 million USD |
| 2008Q3 | 8.5 million USD | 88.1 million USD |
| 2008Q2 | 7.8 million USD | 73.5 million USD |
| 2008Q1 | 10.4 million USD | 80.4 million USD |
| 2007Q4 | 8.4 million USD | 80.2 million USD |
| 2007Q3 | 6.8 million USD | 87.3 million USD |
| 2007Q2 | 8.3 million USD | 78.6 million USD |
| 2007Q1 | 8.4 million USD | 78.0 million USD |
| 2006Q4 | 10.6 million USD | 80.1 million USD |
| 2006Q3 | 8.8 million USD | 84.6 million USD |
| 2006Q2 | 8.3 million USD | 75.9 million USD |
| 2006Q1 | 3.6 million USD | 80.0 million USD |
| 2005Q4 | 9.3 million USD | 79.9 million USD |
| 2005Q3 | 7.4 million USD | 73.3 million USD |
| 2005Q2 | 4.0 million USD | 63.6 million USD |
| 2005Q1 | -224000 USD | 78.4 million USD |
| 2004Q4 | 9.1 million USD | 75.9 million USD |
| 2004Q3 | 9.7 million USD | 81.3 million USD |
| 2004Q2 | -5.1 million USD | 67.8 million USD |
| 2004Q1 | 2.6 million USD | 25.5 million USD |
| 2003Q4 | 1.6 million USD | 19.2 million USD |
| 2003Q3 | 2.1 million USD | 23.8 million USD |
| 2003Q2 | 1.4 million USD | 19.4 million USD |
PBH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -82.3 million USD | 1.1 billion USD |
| 2022 | 205.4 million USD | 1.1 billion USD |
| 2021 | 164.7 million USD | 943.4 million USD |
| 2020 | 142.3 million USD | 963.0 million USD |
| 2019 | -35.8 million USD | 975.8 million USD |
| 2018 | 339.6 million USD | 1.0 billion USD |
| 2017 | 69.4 million USD | 882.1 million USD |
| 2016 | 99.9 million USD | 806.2 million USD |
| 2015 | 78.3 million USD | 714.6 million USD |
| 2014 | 72.6 million USD | 601.9 million USD |
| 2013 | 65.5 million USD | 623.6 million USD |
| 2012 | 37.2 million USD | 441.1 million USD |
| 2011 | 29.2 million USD | 336.5 million USD |
| 2010 | 32.1 million USD | 302.0 million USD |
| 2009 | -186.8 million USD | 312.7 million USD |
| 2008 | 33.9 million USD | 326.6 million USD |
| 2007 | 36.1 million USD | 318.6 million USD |
| 2006 | 26.3 million USD | 296.7 million USD |
| 2005 | 13.5 million USD | 303.3 million USD |
| 2004 | 4.2 million USD | 87.9 million USD |
| 2003 | -14.9 million USD | 71.7 million USD |
| 2002 | 545000 USD | 46.3 million USD |
| 2001 | 2.5 million USD | 8.7 million USD |
PBH
Price: $71.12
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.61 USD
P/E Ratio: -41.62
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 211300
Ebitda: 92.0 millionMarket Capitalization: 3.4 billion
Average Dividend Frequency: 1